AGP Executive Report
Last update: 3 minutes agoVeterinary & FDA Recall: American Regent recalled Adequan injections for dogs and horses after glass fibers were detected in specific lots, urging owners and vets to stop use and report issues. Pet Vaccines: New guidance updates for canine and feline vaccination schedules highlight a key change for kittens’ FVRCP boosters and expanded FeLV recommendations for younger cats. AI in Care Delivery: Medical Metrics Diagnostics and RAYUS Radiology teamed up to bring SpineCAMP AI spine analytics into Utah imaging workflows, aiming to standardize objective spinal motion measurements. Health Policy & Affordability: Massachusetts Gov. Healey rolled out health affordability steps targeting premiums and drug costs, including a push to grow primary care spending through MassHealth. Primary Care Payment Reform: CMS is asking how primary care should be redesigned and valued under the 2027 Medicare Physician Fee Schedule. Clinical AI Payment Reality Check: A new report warns reimbursement models may not fit how clinical AI actually changes clinician workload and decision-making. Medicaid Mental Health Oversight: Research finds a small set of large corporate firms now shapes adolescent Medicaid behavioral health care, with care patterns varying by parent company. Data Privacy Scrutiny: FTC action against Hims & Hers alleges sharing sensitive health data with ad partners, triggering investor fallout and legal interest. Community Health Planning: UChicago Medicine Northwest Indiana released its first Community Health Needs Assessment and improvement plan after 700+ resident and stakeholder inputs. Public Health Integrity: Health NZ faced backlash after a senior official allegedly posed as a patient to gather info about bowel cancer screening outside the national program. Tech & Delivery Debate: Drone package delivery in Michigan is reigniting fights over noise, privacy, and who regulates flights. Clinical Trial Updates: Vertex’s reported deal talks with Crinetics and multiple biotech earnings/updates kept pharma M&A and pipeline momentum in focus.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.